The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  The Lancet Respiratory Medicine

• Publication date

  2017-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S2213-2600(17)30079-6PMID 28344011
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• High-dose rifampicin, moxifl oxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial

  2019cited by this paper
• High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial

  2017cited by this paper
• Outcomes, infectiousness, and transmission dynamics of patients with extensively drug-resistant tuberculosis and home-discharged patients with programmatically incurable tuberculosis: a prospective cohort study.

  2017cited by this paper
• Defining the optimal dose of rifapentine for pulmonary tuberculosis: Exposure–response relations from two phase II clinical trials

  2017cited by this paper
• Combating drug-resistant tuberculosis: the unexpected benefits of bedaquiline.

  2017cited by this paper
• Transmission of Extensively Drug‐Resistant Tuberculosis in South Africa

  2017cited by this paper
• Drug-resistant tuberculosis clinical trials: proposed core research definitions in adults.

  2016cited by this paper
• Global Progress and Challenges in Implementing New Medications for Treating Multidrug-Resistant Tuberculosis

  2016cited by this paper
• β-Lactams against Tuberculosis--New Trick for an Old Dog?

  2016cited by this paper
• Global burden of drug-resistant tuberculosis in children: a mathematical modelling study.

  2016cited by this paper
• Efficacy, safety and tolerability of linezolid for the treatment of XDR-TB: a study in China

  2016cited by this paper
• The effect of surgery on the outcome of treatment for multidrug-resistant tuberculosis: a systematic review and meta-analysis

  2016cited by this paper
• Drug Concentration Thresholds Predictive of Therapy Failure and Death in Children With Tuberculosis: Bread Crumb Trails in Random Forests

  2016cited by this paper
• A new trial design to accelerate tuberculosis drug development: the Phase IIC Selection Trial with Extended Post-treatment follow-up (STEP)

  2016cited by this paper
• Amikacin Optimal Exposure Targets in the Hollow-Fiber System Model of Tuberculosis

  2016cited by this paper
• XDR-TB transmission in London: Case management and contact tracing investigation assisted by early whole genome sequencing.

  2016cited by this paper
• Treatment Outcomes in Multidrug-Resistant Tuberculosis.

  2016cited by this paper
• Adverse Events Associated With the Treatment of Multidrug-Resistant Tuberculosis: A Systematic Review and Meta-analysis

  2016cited by this paper
• The implications of whole-genome sequencing in the control of tuberculosis

  2016cited by this paper
• A Combination Regimen Design Program Based on Pharmacodynamic Target Setting for Childhood Tuberculosis: Design Rules for the Playground

  2016cited by this paper
• Role of gyrB Mutations in Pre-extensively and Extensively Drug-Resistant Tuberculosis in Thai Clinical Isolates

  2016cited by this paper
• Artificial Intelligence and Amikacin Exposures Predictive of Outcomes in Multidrug-Resistant Tuberculosis Patients

  2016cited by this paper
• Determination of MIC Breakpoints for Second-Line Drugs Associated with Clinical Outcomes in Multidrug-Resistant Tuberculosis Treatment in China

  2016cited by this paper
• Mycobacterium tuberculosis whole genome sequencing and protein structure modelling provides insights into anti-tuberculosis drug resistance

  2016cited by this paper
• Compensatory Mutations of Rifampin Resistance Are Associated with Transmission of Multidrug-Resistant Mycobacterium tuberculosis Beijing Genotype Strains in China

  2016cited by this paper
• Selected questions and controversies about bedaquiline: a view from the field.

  2016cited by this paper
• Rapid Drug Susceptibility Testing of Drug-Resistant Mycobacterium tuberculosis Isolates Directly from Clinical Samples by Use of Amplicon Sequencing: a Proof-of-Concept Study

  2016cited by this paper
• Description of compensatory gyrA mutations restoring fluoroquinolone susceptibility in Mycobacterium tuberculosis.

  2016cited by this paper
• The Non-Linear Child: Ontogeny, Isoniazid Concentration, and NAT2 Genotype Modulate Enzyme Reaction Kinetics and Metabolism

  2016cited by this paper
• Whole genome sequencing of Mycobacterium tuberculosis for detection of recent transmission and tracing outbreaks: A systematic review.

  2016cited by this paper
• Naïve-pooled pharmacokinetic analysis of pyrazinamide, isoniazid and rifampicin in plasma and cerebrospinal fluid of Vietnamese children with tuberculous meningitis

  2016cited by this paper
• Antibiotic stewardship for drug resistant tuberculosis

  2016cited by this paper
• Psychological and Educational Intervention to Improve Tuberculosis Treatment Adherence in Ethiopia Based on Health Belief Model: A Cluster Randomized Control Trial

  2016cited by this paper
• Drug-drug interactions between bedaquiline and the antiretrovirals lopinavir/ritonavir and nevirapine in HIV-infected patients with drug-resistant TB.

  2016cited by this paper
• Delamanid Coadministered with Antiretroviral Drugs or Antituberculosis Drugs Shows No Clinically Relevant Drug-Drug Interactions in Healthy Subjects

  2016cited by this paper
• Delamanid susceptibility testing of Mycobacterium tuberculosis using the resazurin microtitre assay and the BACTEC™ MGIT™ 960 system.

  2016cited by this paper
• Moxifloxacin's Limited Efficacy in the Hollow-Fiber Model of Mycobacterium abscessus Disease

  2016cited by this paper
• Genetic Determinants of Drug Resistance in Mycobacterium tuberculosis and Their Diagnostic Value.

  2016cited by this paper
• Characteristics and costs of multidrug-resistant tuberculosis in-patient care in the United States, 2005-2007.

  2016cited by this paper
• A Long-term Co-perfused Disseminated Tuberculosis-3D Liver Hollow Fiber Model for Both Drug Efficacy and Hepatotoxicity in Babies

  2016cited by this paper
• Linezolid for Infants and Toddlers With Disseminated Tuberculosis: First Steps

  2016cited by this paper
• Identifying Likely Transmission Pathways within a 10-Year Community Outbreak of Tuberculosis by High-Depth Whole Genome Sequencing

  2016cited by this paper
• Clinical use of whole genome sequencing for Mycobacterium tuberculosis

  2016cited by this paper
• Optimal Clinical Doses of Faropenem, Linezolid, and Moxifloxacin in Children With Disseminated Tuberculosis: Goldilocks

  2016cited by this paper
• Multidrug-Resistant TB

  2016cited by this paper
• Effectiveness and safety of meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB

  2016cited by this paper
• Identifying Hotspots of Multidrug-Resistant Tuberculosis Transmission Using Spatial and Molecular Genetic Data.

  2016cited by this paper
• Remote monitoring of Xpert® MTB/RIF testing in Mozambique: results of programmatic implementation of GxAlert.

  2016cited by this paper
• Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant pulmonary tuberculosis.

  2015cited by this paper
• Hollow Fiber System Model for Tuberculosis: The European Medicines Agency Experience.

  2015cited by this paper
• F-A-S-T: a refocused, intensified, administrative tuberculosis transmission control strategy.

  2015cited by this paper
• Clofazimine for the treatment of multidrug-resistant tuberculosis: prospective, multicenter, randomized controlled study in China.

  2015cited by this paper
• Forecasting Accuracy of the Hollow Fiber Model of Tuberculosis for Clinical Therapeutic Outcomes.

  2015cited by this paper
• Institutional Tuberculosis Transmission. Controlled Trial of Upper Room Ultraviolet Air Disinfection: A Basis for New Dosing Guidelines.

  2015cited by this paper
• Correlations Between the Hollow Fiber Model of Tuberculosis and Therapeutic Events in Tuberculosis Patients: Learn and Confirm.

  2015cited by this paper
• Evolutionary history and global spread of the Mycobacterium tuberculosis Beijing lineage

  2015cited by this paper
• Directly observed therapy for treating tuberculosis

  2015cited by this paper
• Mutations in Genes for the F420 Biosynthetic Pathway and a Nitroreductase Enzyme Are the Primary Resistance Determinants in Spontaneous In Vitro-Selected PA-824-Resistant Mutants of Mycobacterium tuberculosis

  2015cited by this paper
• Diagnostic Performance of the New Version (v2.0) of GenoType MTBDRsl Assay for Detection of Resistance to Fluoroquinolones and Second-Line Injectable Drugs: a Multicenter Study

  2015cited by this paper
• Bedaquiline in the treatment of multidrug- and extensively drug-resistant tuberculosis

  2015cited by this paper
• HIV treatment cascade in tuberculosis patients

  2015cited by this paper
• Tuberculosis control in China: use of modelling to develop targets and policies

  2015cited by this paper
• Pharmacokinetics of Bedaquiline in Cerebrospinal Fluid and Serum in Multidrug-Resistant Tuberculous Meningitis.

  2015cited by this paper
• Clofazimine shortens the duration of the first-line treatment regimen for experimental chemotherapy of tuberculosis

  2015cited by this paper
• Systematic Analysis of Hollow Fiber Model of Tuberculosis Experiments.

  2015cited by this paper
• High effectiveness of a 12-month regimen for MDR-TB patients in Cameroon.

  2015cited by this paper
• The prospective evaluation of the TB strain typing service in England: a mixed methods study

  2015cited by this paper
• Towards earlier inclusion of Children in Tuberculosis (TB) drugs trials: Consensus statements from an Expert Panel

  2015cited by this paper
• Bactericidal activity of pyrazinamide and clofazimine alone and in combinations with pretomanid and bedaquiline.

  2015cited by this paper
• Presence of infection influences the epithelial lining fluid penetration of oral levofloxacin in adult patients.

  2015cited by this paper
• Sputum culture conversion as a prognostic marker for end-of-treatment outcome in patients with multidrug-resistant tuberculosis: a secondary analysis of data from two observational cohort studies.

  2015cited by this paper
• Genomic epidemiology of multidrug-resistant Mycobacterium tuberculosis during transcontinental spread.

  2015cited by this paper
• Mycobacterium tuberculosis pncA Polymorphisms That Do Not Confer Pyrazinamide Resistance at a Breakpoint Concentration of 100 Micrograms per Milliliter in MGIT

  2015cited by this paper
• High Frequency of Resistance, Lack of Clinical Benefit, and Poor Outcomes in Capreomycin Treated South African Patients with Extensively Drug-Resistant Tuberculosis

  2015cited by this paper
• Molecular Epidemiological Interpretation of the Epidemic of Extensively Drug-Resistant Tuberculosis in South Africa

  2015cited by this paper
• Detection of Low-Level Mixed-Population Drug Resistance in Mycobacterium tuberculosis Using High Fidelity Amplicon Sequencing

  2015cited by this paper
• Treatment of drug-resistant tuberculosis with bedaquiline in a high HIV prevalence setting: an interim cohort analysis.

  2015cited by this paper
• Pharmacokinetic-pharmacodynamic and dose-response relationships of antituberculosis drugs: recommendations and standards for industry and academia.

  2015cited by this paper
• A Global Perspective on Pyrazinamide Resistance: Systematic Review and Meta-Analysis

  2015cited by this paper
• A Collaborative Approach for “ReSeq-ing” Mycobacterium tuberculosis Drug Resistance: Convergence for Drug and Diagnostic Developers

  2015cited by this paper
• The Hollow Fiber System Model in the Nonclinical Evaluation of Antituberculosis Drug Regimens.

  2015cited by this paper
• Pharmacodynamic Modeling of Bacillary Elimination Rates and Detection of Bacterial Lipid Bodies in Sputum to Predict and Understand Outcomes in Treatment of Pulmonary Tuberculosis

  2015cited by this paper
• Amikacin Pharmacokinetics/Pharmacodynamics in a Novel Hollow-Fiber Mycobacterium abscessus Disease Model

  2015cited by this paper
• Nonclinical models for antituberculosis drug development: a landscape analysis.

  2015cited by this paper
• Cost-Effectiveness of Initiating Antiretroviral Therapy at Different Points in TB Treatment in HIV-TB Coinfected Ambulatory Patients in South Africa

  2015cited by this paper
• Association between Multidrug-Resistant Tuberculosis and Risk Factors in China: Applying Partial Least Squares Path Modeling

  2015cited by this paper
• Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort study

  2015cited by this paper
• PhyResSE: a Web Tool Delineating Mycobacterium tuberculosis Antibiotic Resistance and Lineage from Whole-Genome Sequencing Data

  2015cited by this paper
• Tracking a tuberculosis outbreak over 21 years: strain-specific single-nucleotide polymorphism typing combined with targeted whole-genome sequencing.

  2015cited by this paper
• Management of drug resistantTB in patients with HIV co-infection

  2015cited by this paper
• Evolution of Extensively Drug-Resistant Tuberculosis over Four Decades: Whole Genome Sequencing and Dating Analysis of Mycobacterium tuberculosis Isolates from KwaZulu-Natal

  2015cited by this paper
• Amikacin Concentrations Predictive of Ototoxicity in Multidrug-Resistant Tuberculosis Patients

  2015cited by this paper
• Association between Regimen Composition and Treatment Response in Patients with Multidrug-Resistant Tuberculosis: A Prospective Cohort Study

  2015cited by this paper
• Mycobacterial DNA Extraction for Whole-Genome Sequencing from Early Positive Liquid (MGIT) Cultures

  2015cited by this paper
• The burden of transmitted multi-drug resistance among epidemics of tuberculosis: A transmission model

  2015cited by this paper
• Extremely High Mutation Rate of HIV-1 In Vivo

  2015cited by this paper
• The Movement of Multidrug-Resistant Tuberculosis across Borders in East Africa Needs a Regional and Global Solution

  2015cited by this paper
• Loss from Treatment for Drug Resistant Tuberculosis: Risk Factors and Patient Outcomes in a Community-Based Program in Khayelitsha, South Africa

  2015cited by this paper
• Compassionate use of bedaquiline for the treatment of multidrug-resistant and extensively drug-resistant tuberculosis: interim analysis of a French cohort.

  2015cited by this paper
• High Prevalence of inhA Promoter Mutations among Patients with Drug-Resistant Tuberculosis in KwaZulu-Natal, South Africa

  2015cited by this paper

• Durable three-year outcomes and persistent neuropathy following nine-month all-oral regimens for rifampicin-resistant tuberculosis: a multicentre cohort study in China.

  2026cites this paper
• A Novel Triterpene From Erica Miranjiana with Potential Anti-Tubercular Activity

  2026cites this paper
• From clinical phenotypes to genomic signatures: machine learning integration for precision tuberculosis treatment prediction

  2026cites this paper
• Lineages of Mycobacterium tuberculosis complex associated with pulmonary drug-resistant tuberculosis in Africa: a systematic review.

  2026cites this paper
• Inhalable Chitosan Microparticles: A Spray-Drying Approach for Enhanced Pulmonary Delivery of Rifampicin

  2026cites this paper
• Network analysis of symptom clusters among patients with pulmonary tuberculosis: a cross-sectional study.

  2026cites this paper
• A retrospective study on the prevalence of pre-XDR and XDR Mycobacterium tuberculosis in the South Coastal Region of Andhra Pradesh, India

  2026influential citation
• Structural exploration of thiazole urea-based Gyr B inhibitors through different computational approaches: Bayesian classification, molecular docking and free energy-inspired molecular dynamics simulation.

  2026cites this paper
• Evolving profiles and treatment success predictors among tuberculosis patients in Uganda from 2019 to 2023: a registry based study.

  2026cites this paper
• The burden of tuberculosis and drug resistance in 22 Sub-Saharan African countries, 1990–2021: a GBD 2021 analysis and progress towards WHO 2035 targets with projections to 2050

  2025cites this paper
• TCS-isatin-INH triads as potent and selective anti-mycobacterial with high efficacy against Mycobacterium tuberculosis

  2025cites this paper
• MOLECULAR DOCKING STUDIES OF ISATIN-LINKED CHALCONE DERIVATIVES AS ANTI-TB DRUG CANDIDATES AND THEIR ADMET PREDICTION

  2025cites this paper
• A Stochastic Projection for Tuberculosis Elimination in Indonesia by 2030

  2025cites this paper
• Manganese as a Cofactor in the Immunity of Mycobacterium tuberculosis Infection

  2025cites this paper
• Predictors of drug-resistant TB outcomes: Body mass index, HIV, and comorbidities

  2025cites this paper
• Dual Mutations in MSMEG_0965 and MSMEG_1380 Confer High-Level Resistance to Bortezomib and Linezolid by Both Reducing Drug Intake and Increasing Efflux in Mycobacterium smegmatis

  2025cites this paper
• A comparative study using Xpert MTB/RIF and culture methods evaluates MassARRAY technology for rapid detection of Mycobacterium tuberculosis and drug resistance

  2025cites this paper
• Functional and structural insights into the multicopper oxidase MmcO from Mycobacterium tuberculosis: implications for drug targeting

  2025cites this paper
• Impaired Lung Function and Quality of Life Outcomes in Patients with Tuberculosis: A Cross-Sectional Study

  2025cites this paper
• Microbial-based natural products as potential inhibitors targeting DNA gyrase B of Mycobacterium tuberculosis: an in silico study

  2025cites this paper
• Targeting InhA in drug-resistant Mycobacterium tuberculosis: potent antimycobacterial activity of diaryl ether dehydrozingerone derivatives

  2025cites this paper
• Awareness of management of pulmonary multidrug-resistant tuberculosis (MDR-TB) among private practitioners in suburban areas of Pune city, India: Input for developing an educational tool

  2025cites this paper
• Refractory splenic tuberculosis in acute myeloid Leukemia: The role of advanced diagnostics and surgical intervention

  2025cites this paper
• Machine learning-assisted genomic profiling to identify differences between Bacillus Calmette-Guérin (BCG) vaccine strains and non-BCG wild-type Mycobacterium bovis

  2025cites this paper
• Characteristics of compensatory mutations in rifampicin-resistant tuberculosis and their association with compensated transmission in Ningbo, China

  2025cites this paper
• Anti-tuberculosis activity of 14-deoxy-11,12-didehydroandrographolide from Andrographis paniculata against drug-sensitive and MDR Mycobacterium tuberculosis

  2025cites this paper
• Antimicrobial Resistance of Mycobacterium Tuberculosis A Global Health Challenge

  2025cites this paper
• Pathogen-Specific Drug Metabolism in Tuberculosis: Enzymes, Metabolic Pathways, and New Horizons in Therapeutic Development.

  2025cites this paper
• Transmission characteristics of tuberculosis in the high-TB-burden region of Southwest China

  2025cites this paper
• Integrated Artificial Intelligence Framework for Tuberculosis Treatment Abandonment Prediction: A Multi-Paradigm Approach

  2025cites this paper
• Resistance characteristics of culture-positive tuberculosis from 2015 to 2022

  2025cites this paper
• Development of an inhalable dry powder of mycobacteriophage D29 using thin-film freeze-drying.

  2025cites this paper
• Temporal Dynamics and Regional Disparities in HIV/AIDS and Extensively Drug-Resistant Tuberculosis Mortality in South Asia: A Systemic Analysis of Global Burden of Disease Data (1993–2021)

  2025cites this paper
• Rifampicin and isoniazid resistance not promote fluoroquinolone resistance in Mycobacterium smegmatis

  2025cites this paper
• Immune Defense and Immune Evasion in Mycobacterium Tuberculosis Infection: Inspirations and Challenges for Host Directed Therapy.

  2025cites this paper
• Enhanced tuberculosis control via leveraging dendritic cell-mediated Th1 responses in preventive and immunotherapeutic vaccine strategies.

  2025cites this paper
• Integrative transcriptome-based drug repurposing in tuberculosis

  2025cites this paper
• Feasibility and acceptability of GeneXpert MTB/XDR implementation among healthcare workers in three low-middle income African countries

  2025cites this paper
• Candidate transmission survival genome of Mycobacterium tuberculosis

  2025cites this paper
• Treatment Outcome of Bedaquiline-Based Oral Regimens for Drug-Resistant Tuberculosis in a High-Burden Setting.

  2025cites this paper
• The Antibiotic-Resistant Protein MfpA Modulates Host Cell Apoptosis and Promotes Mycobacterial Survival by Targeting Mitochondria and Regulating the NF-κB Signaling Pathway

  2025cites this paper
• Combating Multi-drug Resistant Mycobacterium Species by Efflux Pump Inhibitors: Contemporary Trends

  2025cites this paper
• Cryo-EM reveals structural diversity in prolate-headed mycobacteriophage Mycofy1.

  2025cites this paper
• Evaluation of the Roche cobas MTB and MTB-RIF/INH for detecting Mycobacterium tuberculosis complex and resistance to isoniazid and rifampicin: A prospective, multicenter diagnostic accuracy study.

  2025cites this paper
• Mycobacterium fortuitum Infection Mimicking an Odontogenic Abscess: Report of a Pediatric Case with Relevant Literature Analysis

  2025influential citation
• Cost-effectiveness of Targeted Next Generation Sequencing for TB drug-resistance testing as an alternative to the standard of care in South Africa

  2025cites this paper
• Outdoor particulate matter and risk of drug resistance for workers and farmers with pulmonary tuberculosis: a population-based time-series study in Suzhou, China

  2025cites this paper
• Innovative Strategies for Combating Multidrug-Resistant Tuberculosis: Advances in Drug Delivery Systems and Treatment

  2025cites this paper
• Using Machine Learning Methods to Predict Early Treatment Outcomes for Multidrug-Resistant or Rifampicin-Resistant Tuberculosis to Enhance Patient Cure Rates: Development and Validation of Multiple Models

  2025cites this paper
• Epidemiological trends and burden of mortality from HIV/AIDS and multidrug-resistant tuberculosis without extensive drug-resistance across Africa: A global burden of disease analysis (1990–2021)

  2025cites this paper
• Discovery of novel inhibitors for malate synthase of Mycobacterium Tuberculosis from natural products.

  2025cites this paper
• Global trajectory and spatiotemporal epidemiological landscape of multidrug-resistant tuberculosis of spanning 46 years (1990–2035): implications for achieving global end TB goals

  2025cites this paper
• Associations between host efflux pump gene polymorphisms (ABCB1, ABCC1, ABCG2) and drug-resistant tuberculosis in a Chinese cohort.

  2025cites this paper
• Relationship between duration of treatment and urine protein in pulmonary tuberculosis patients

  2025cites this paper
• Genetic Analysis of Molecular Mechanisms of Drug Resistance in Mycobacterium tuberculosis Against Four Major First-Line Anti-Tuberculosis Drugs (Isoniazid, Rifampin, Ethambutol, and Pyrazinamide)

  2025cites this paper
• Drug-resistant tuberculosis: a priority pathogen for enhanced public health research and practice

  2025cites this paper
• Nomogram model for prediction of pulmonary tuberculosis patients with intestinal tuberculosis

  2025cites this paper
• Comparative genomic analysis of drug-resistant and drug-sensitive tuberculosis strains and their impact on cough severity

  2025cites this paper
• Synthesis and anti-mycobacterial activity of novel medium-chain β-lactone derivatives: a multi-target strategy to combat Mycobacterium abscessus

  2025cites this paper
• AI-powered risk prediction of tuberculosis reactivation in latently infected individuals.

  2025cites this paper
• Stigma and health-related quality of life (HRQoL) among people with multidrug-resistant tuberculosis (MDR-TB): A cross-sectional study in Indonesia

  2025cites this paper
• Trend and forecast analysis of the changing disease burden of tuberculosis in China, 1990–2021

  2025cites this paper
• Harnessing Actinobacteria secondary metabolites for tuberculosis drug discovery: Historical trends, current status and future outlooks

  2025cites this paper
• Identification of core biomarkers for tuberculosis progression through bioinformatics analysis and in vitro research

  2025cites this paper
• The Biosafety Level 3 (BSL-3) Laboratory Readiness for Emerging Pathogens: A Review Study

  2024cites this paper
• Visual detection of Mycobacterium tuberculosis in exhaled breath using N95 enrichment respirator, RPA, and lateral flow assay.

  2024cites this paper
• Triage test for all-oral drug-resistant tuberculosis (DR-TB) regimen: a phase IV study to assess effectiveness, feasibility, acceptability and cost-effectiveness of the Xpert MTB/XDR assay for rapid triage and treatment of DR-TB

  2024cites this paper
• Immunopathology in human tuberculosis.

  2024cites this paper
• Benzothiazinone analogs as Anti-Mycobacterium tuberculosis DprE1 irreversible inhibitors: Covalent docking, validation, and molecular dynamics simulations

  2024cites this paper
• Antibiotic Resistance of Escherichia coli and Salmonella spp. Strains Isolated from Some Selected Poultry Farms in the Oforikrom Municipality Kumasi, Ghana

  2024cites this paper
• Study on artificial intelligence to judge the activity of tuberculomas

  2024cites this paper
• The identification of essential cellular genes is critical for validating drug targets.

  2024cites this paper
• Therapeutic drug monitoring in tuberculosis

  2024cites this paper
• Examining Diagnostic Efficacy: GeneXpert Versus Traditional Staining Techniques With Culture in the Diagnosis of Tuberculosis

  2024cites this paper
• HIV and body mass index are associated with prolonged corrected QT interval among people with drug-resistant tuberculosis on bedaquiline-containing regimen in Uganda

  2024cites this paper
• Host and bacterial lipid metabolism during tuberculosis infections: possibilities to synergise host- and bacteria-directed therapies

  2024cites this paper
• Anti-tuberculosis (TB) Drug Stockouts in India: Implementation Gaps, Implications for Patients and Public Health

  2024cites this paper
• Assessing the quality of life in patients with drug-resistant tuberculosis: a cross-sectional study

  2024cites this paper
• Beyond copper: examining the significance of His-mutations in mycobacterial GroEL1 HRCT for Ni(II) complex stability and formation.

  2024cites this paper
• Multidrug-resistant tuberculosis

  2024influential citation
• Estimation of country-specific tuberculosis resistance antibiograms using pathogen genomics and machine learning

  2024cites this paper
• Epidemiology and Management of Infections in Liver Transplant Recipients

  2024cites this paper
• Drug-resistant tuberculosis: a persistent global health concern

  2024cites this paper
• Causal associations of gut microbiota and pulmonary tuberculosis: a two-sample Mendelian randomization study

  2024cites this paper
• Unveiling the complexity of rifampicin drug susceptibility testing in Mycobacterium tuberculosis: comparative analysis with next-generation sequencing.

  2024cites this paper
• Assessing Hepatotoxicity in Novel and Standard Short Regimens for Rifampicin-Resistant Tuberculosis: Insights from the TB-TRUST and TB-TRUST -plus Trials.

  2024cites this paper
• Anterior mediastinal mass in HIV patient with disseminated tuberculosis – An atypical case report

  2024cites this paper
• Preliminary structure−activity relationships analysis on N-(3,5-dichlorophenyl)-4,5-dihydronaphtho[1,2-d]thiazol-2-amine, a disruptor of mycobacterial energetics

  2024cites this paper
• Viewpoint on WHO implementation guidance on tuberculosis infection prevention and control

  2024cites this paper
• Differentiation complex sputum microbiome in patients suspected TB pulmonary

  2024cites this paper
• A first-in-class leucyl-tRNA synthetase inhibitor, ganfeborole, for rifampicin-susceptible tuberculosis: a phase 2a open-label, randomized trial

  2024cites this paper
• Applying a Combined Model to Evaluate the Risk of Poor Treatment Outcomes in Rifampicin Resistant Tuberculosis Patients: A Multicenter Retrospective Study

  2024cites this paper
• Effect of Vitamin D Supplementation on the Treatment of Pulmonary Tuberculosis Patients in Different Polymorphisms of the Vitamin D Receptor

  2024cites this paper
• Indole-containing inhibitors with improved efficacy targeting the gyrase of Mycobacterium tuberculosis

  2024cites this paper
• Community-acquired multidrug-resistant pneumonia, bacteraemia, and infective endocarditis: A case report

  2024cites this paper
• Host-Pathogen Interaction: Biology and Public Health.

  2024cites this paper
• Prison as a driver of recent transmissions of multidrug-resistant tuberculosis in Callao, Peru: a cross-sectional study

  2024cites this paper
• TB-DROP: deep learning-based drug resistance prediction of Mycobacterium tuberculosis utilizing whole genome mutations

  2024cites this paper
• Non-adherence to anti-tuberculosis treatment and associated factors among TB patients in public health facilities of Hossana town, Southern Ethiopia, 2022

  2024cites this paper
• Impacts of body weight change on treatment outcomes in patients with multidrug-resistant tuberculosis in Northwest Ethiopia

  2024cites this paper